Table 2 Pathological response in patients who underwent resection
| Â | Category | All patients (n=65) | nICT (n=26) | nCT (n=39) | P | |
|---|---|---|---|---|---|---|
ypTNM | Â | Â | Â | Â | 0.746 | |
| Â | I | 26 (40.0%) | 12 (46.2%) | 14 (53.8%) | Â | |
II | 7 (10.8%) | 3 (42.9%) | 4 (57.1%) | |||
IIIA | 8 (12.3%) | 4 (50.0%) | 4 (50.0%) | |||
IIIB | 17 (26.2%) | 5 (29.4%) | 12 (70.6%) | |||
IVA | 7 (10.8%) | 2 (28.6%) | 5 (71.4%) | |||
TRG | Â | Â | Â | Â | 0.108 | |
| Â | 0 | 7 (10.8%) | 3 (42.9%) | 4 (57.1%) | Â | |
1 | 10 (15.4%) | 3 (30.0%) | 7 (70.0%) | Â | ||
2 | 11 (16.9%) | 8 (72.7%) | 3 (27.3%) | Â | ||
3 | 37 (56.9%) | 12 (32.4%) | 25 (67.6%) | Â | ||
Pathological response | ||||||
| Â | pCR | Â | Â | Â | Â | 1.000 |
| Â | Â | Yes | 7 (10.8%) | 3 (42.9%) | 4 (57.1%) | Â |
No | 58 (89.2%) | 23 (39.7%) | 35 (60.3%) | |||
MPR | Â | Â | Â | Â | 0.645 | |
| Â | Yes | 17 (26.2%) | 6 (35.3%) | 11 (64.7%) | Â | |
No | 48 (73.8%) | 20 (41.7%) | 28 (58.3%) | |||
TNM stage of tumor | Â | Â | Â | 0.732 | ||
| Â | Down | 29 (44.6%) | 13 (44.8%) | 16 (55.2%) | Â | |
Up | 18 (27.7%) | 7 (38.9%) | 11 (61.1%) | |||
Stable | 18 (27.7%) | 6 (33.3%) | 12 (66.7%) | |||